Table 1.
Baseline Characteristics of 88 older women with endometrial cancer who received chemotherapy and radiation
| Characteristic | N | (%) |
|---|---|---|
|
| ||
| Age at diagnosis | ||
|
|
||
| 60 to <70 | 48 | 54.5 |
| 70 to <75 | 30 | 34.1 |
| 75 to 82 | 10 | 11.4 |
|
| ||
| Race | ||
|
|
||
| Caucasian | 70 | 79.6 |
| Hispanic | 8 | 9.1 |
| African American | 10 | 11.4 |
|
| ||
| Lives alone | 19 | 25.0 |
|
| ||
| Education | ||
| High school or less | 14 | 16.0 |
| Beyond high school | 31 | 35.2 |
| Unknown | 43 | 48.9 |
|
| ||
| Employed | 19 | 21.6 |
|
| ||
| ECOG-PS | ||
| 0 | 71 | 81.6 |
| 1 | 14 | 16.1 |
| 2 | 2 | 2.3 |
|
| ||
| BMI (WHO categories) | ||
| <20 kg/m2 | 19 | 24.1 |
| 20–25 kg/m2 | 32 | 40.5 |
| >25 kg/m2 | 28 | 35.4 |
|
| ||
| Weight loss | 12 | 13.6% |
|
| ||
| History of smoking | 35 | 40.2% |
|
| ||
| Osteopenia/Osteoporosis | 16 | 18.2% |
|
| ||
| Charlson comorbidity score | ||
| 0 | 25 | 28.7% |
| 1 | 31 | 35.6% |
| 2 | 18 | 20.7% |
| > 2 | 13 | 14.9% |
|
| ||
| Comorbidities | ||
| HTN | 48 | 54.5% |
| DM | 14 | 15.9% |
| Previous Cancer | 13 | 14.8% |
| Pulmonary | 6 | 6.8% |
| CHF | 4 | 4.5% |
| MI | 3 | 3.4% |
|
| ||
| Depression or Anxiety | 32 | 36.4% |
|
| ||
| FIGO Cancer stage | ||
| I | 22* | 25.3% |
| II | 6 | 6.9% |
| III | 50 | 57.5% |
| IV | 9 | 10.3% |
|
| ||
| Tumor grade | ||
| 1 | 2 | 2.3 |
| 2 | 13 | 14.8 |
| 3 | 67 | 76.1 |
| Unknown | 6 | 6.8 |
|
| ||
| Histology | ||
| Papillary serous | 57 | 64.7 |
| Endometrioid adenocarcinoma | 22 | 25 |
| Clear cell carcinoma | 5 | 5.7 |
| Carcinosarcoma | 4 | 4.6 |
|
| ||
| Frailty score factors | ||
| ECOG-PS ≥ 1 | 16 | 18.4 |
| BMI < 20 kg/m2 | 19 | 24.1 |
| Unintentional weight loss | 12 | 13.6 |
| Albumin < 3.5 mg/dL | 21 | 23.9 |
| Hemoglobin < 10 mg/dL | 14 | 15.9 |
| Osteopenia/Osteoporosis | 16 | 18.2 |
*
Categories may not add up to 100% due to missing values